Healthcare -
Biotechnology - NASDAQ - US
$ 40.72
0.271 %
$ 2.35 B
Market Cap
-34.8
P/E
JANX - COST OF REVENUE
Cost of Revenue JANX - Janux Therapeutics, Inc.
1.96 M
LAST VALUE
315.94%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR